AI-Assisted Expression & Solubility Optimization

inquiry

Creative Enzymes applies machine learning and sequence engineering to maximize heterologous expression yield, soluble fraction, and secretion efficiency. Our platform identifies and resolves codon bias, misfolding propensity, aggregation-prone regions, and host incompatibility before construct synthesis, reducing the time and cost from gene to purified protein.

Expression Bottlenecks

Heterologous expression frequently fails to deliver sufficient functional enzyme for research or manufacturing scale. Common bottlenecks include:

Codon Bias Mismatch

Rare codons in the target gene causing translational pausing, frameshifting, or premature termination in the production host.

Aggregation-Prone Regions

Hydrophobic stretches or amyloidogenic sequences driving inclusion body formation or irreversible oligomerization.

Poor Soluble Yield

Low proportion of correctly folded protein relative to total expressed material, inflating purification costs.

Inefficient Secretion

Suboptimal signal peptides, translocation barriers, or folding quality control rejection limiting extracellular accumulation.

Host Toxicity

Enzyme activity or overexpression burden compromising host viability and reducing biomass yield.

These bottlenecks are often predictable from sequence features and host-specific constraints, enabling preemptive engineering rather than reactive troubleshooting.

AI-Guided Sequence Optimization

Our platform targets four sequence-level determinants of expression performance:

Codon Usage

Host-adapted codon optimization balancing translation speed, mRNA stability, and tRNA abundance. Models account for local codon context effects and avoid extreme GC content shifts.

Aggregation Regions

Prediction and disruption of hydrophobic patches, β-sheet-prone segments, and charge-complemented interfaces that drive self-association during or after folding.

Solubility Prediction

Sequence-based scoring of intrinsic solubility, with identification of N-terminal, C-terminal, and internal segments amenable to solubility tag fusion or mutational softening.

Signal Peptide Optimization

In silico screening of natural and engineered signal sequences for translocation efficiency, signal peptidase cleavage accuracy, and compatibility with the target protein's folding kinetics.

Each optimization target is addressed through predictive models trained on paired sequence-expression datasets across multiple host systems.

Host Compatibility Analysis

Expression success depends on the match between protein features and host capabilities. Our analysis evaluates:

Protease Susceptibility

Identification of cleavage sites for host proteases and recommendation of protective mutations or protease-deficient host strains

Chaperone Demand

Assessment of folding complexity relative to host chaperone capacity, with suggestions for co-expression strategies or host engineering

Disulfide Bond Requirements

Detection of non-native disulfide formation in reducing cytoplasmic environments and recommendation of oxidative folding hosts or cysteine substitutions

Post-Translational Modification Needs

Flagging of glycosylation, phosphorylation, or other modification requirements that may dictate host selection or necessitate modification site removal

Host compatibility scoring informs strain selection and process parameter recommendations before experimental testing.

Workflow

AI-Assisted Expression & Solubility Optimization Workflow

1. Sequence Analysis: The target gene is analyzed for codon bias, aggregation propensity, solubility score, and signal peptide efficiency in the intended host. Baseline expression liabilities are ranked by predicted impact on yield.

2. Construct Design: AI models propose optimized coding sequences with adapted codon usage, disrupted aggregation regions, and optional solubility tag fusions. Signal peptides are selected or engineered for secretion targets.

3. Host Selection: Compatibility analysis recommends the optimal expression system based on folding requirements, modification needs, and scalability constraints.

4. Library Construction: Optimized constructs are synthesized with sequence verification. Small variant libraries may be generated to explore alternative signal peptides or solubility tag placements.

5. Expression Screening: Constructs are transformed into the recommended host and evaluated for total yield, soluble fraction, monomeric purity, and biological activity. Secreted products are quantified in the culture medium.

6. Iterative Refinement: Expression data refine codon optimization models and host compatibility predictors. Underperforming constructs are diagnosed and redesigned in a second cycle if necessary.

Wet Lab Validation Support

Sequence optimization must be validated by measurable expression outcomes. Our pipeline provides comprehensive characterization:

Service	Description
Yield Quantification	Total and soluble protein yield by densitometry, ELISA, or activity assay, normalized to biomass or culture volume
Solubility Profiling	Fractionation between soluble and insoluble fractions, with analytical assessment of inclusion body morphology and refolding potential
Monomeric Purity	Size-exclusion chromatography and native PAGE to confirm oligomeric state and absence of aggregates
Secretion Efficiency	Quantification of extracellular versus intracellular product, with signal peptide cleavage verification by N-terminal sequencing
Activity Confirmation	Functional assay of soluble or secreted material to ensure that sequence modifications have not compromised catalytic competence
Scale-Up Assessment	Preliminary evaluation of expression consistency at elevated culture volumes to identify process transfer risks

Validation results inform construct ranking and guide downstream purification and process development.

Related Services

Case Study

Machine Learning Optimization of Enzyme Solubility and Activity

Figure 1. Machine learning model assisted optimization of protein solubility. (Han et al., 2020)

This study developed a machine learning-based optimization strategy to improve enzyme solubility and catalytic performance through short peptide tag design. Using a support vector regression model trained on protein sequence and solubility data, researchers applied an iterative optimization algorithm to evolve peptide tags predicted to enhance protein solubility. Experimental validation showed that tagged enzymes exhibited significantly improved solubility and activity. In particular, tyrosine ammonia lyase displayed more than a twofold increase in solubility and a 250% increase in activity, while two additional enzymes also showed enhanced solubility. The work demonstrates how computational optimization using solubility as a proxy for protein activity can accelerate enzyme engineering for metabolic engineering and biotechnology applications.

FAQs

Q: Which hosts do you support?

A: E. coli, Pichia pastoris, Saccharomyces cerevisiae, mammalian cells (CHO, HEK293), and baculovirus-insect systems.
Q: Can you optimize secretion as well as intracellular expression?

A: Yes. Signal peptide selection, translocation optimization, and folding quality control engineering are integrated components of our secretion-focused designs.
Q: Do you guarantee a specific yield improvement?

A: We guarantee rigorous execution of the optimization workflow with quantitative reporting. Specific yield targets are established as project milestones.
Q: Can expression-optimized variants be further engineered for activity or stability?

A: Yes. Expression-optimized scaffolds serve as robust starting points for subsequent catalytic or stability engineering, or can be co-optimized through multi-objective scoring.
Q: What is the typical timeline?

A: 6–10 weeks per design-test cycle. Most projects achieve target expression within 2 cycles.
Q: Do you provide purified protein?

A: Yes. Purified material can be delivered as an add-on service for validated variants.

References:

Han X, Ning W, Ma X, Wang X, Zhou K. Improving protein solubility and activity by introducing small peptide tags designed with machine learning models. Metabolic Engineering Communications. 2020;11:e00138. doi:10.1016/j.mec.2020.e00138

First Name:

Last Name:

Email *

Phone Number:

Company/Institution:

Country or Region:

Quantity:

Services & Products of Interested *

Project Description:

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services

Online Inquiry